New York City-based Paradigm, whose tech streamlines data aggregation and patient recruitment to speed up clinical trials, launches with a $203M Series A (Maureen Farrell/New York Times)

Maureen Farrell / New York Times:
New York City-based Paradigm, whose tech streamlines data aggregation and patient recruitment to speed up clinical trials, launches with a $203M Series A  —  New York-based Paradigm has raised a significant amount to simplify clinical trials.  Its goal is ambitious, but its challenges are many, researchers say.